Clinical Trial Update: Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 safety trial evaluating bevacizumab (Avastin) with thoracic radiation in non-small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Toxicity | Phase 1 | Status: TERMINATED